March 3, 2017 (Ft. Lauderdale, Florida)
Precision Medical Devices, Inc. (PMD) just inked a contract with North Carolina State University (NCSU) to become its second site to do implants of its revolutionary new bionic Bluetooth-controlled and Bluetooth-adjustable urethral valve device designed to optimally treat severe UI in both humans and canines under the direction of noted veterinarian researcher, Dr. Christopher Adin (DVM).
NCSU and Dr. Adin are highly regarded for the excellent research they do in veterinarian medicine, which many times also translates to important treatments for humans, as will be the case with the PMD technology expecting to become an optimal treatment for both, especially in refractory cases.
Dr. Adin is uniquely qualified to direct this project as he invented, and is currently the primary proponent of, the only currently in-use artificial urinary sphincter (AUS) device for canines. His project series will be focused on maximizing the adaptation of the PMD device technology to the unique challenges that are presented in treating UI in the pet canine market, challenges that far exceed the operational parameters needed to appropriately manage human cases.
The Company continues to negotiate with other noted urologists and uro-gynecologists to do additional implant programs in support of the work we are doing under the direction of our Chief of Surgery, Dr. Angelo Gousse with great assistance from Dr. Christopher Gomez and the University of Miami DVR team.
Notwithstanding that the Company expects that such technology will be usable to treat a number of other medical conditions in humans, including, but not limited to; fecal incontinence, morbid obesity, GERDs and ED, we now also believe the technology will be useful in treating additional conditions more associated with canine health problems, including providing a new tool to accomplish the occlusion of intrahepatic portocaval shunts in dogs.